Anda Nugroho, Badan Kebijakan Fiskal, Kementerian Keuangan RI
If Indonesia can maximise its role as the hub for the production and distribution of Chinese COVID-19 vaccines for Southeast Asia region, the country may gain profits.
Michael Wade, International Institute for Management Development (IMD) and Elizabeth Teracino, International Institute for Management Development (IMD)
Most people would be content to pull off one of the world’s top five IPOs, but Jack Ma is on course for his second.
In 2016, America’s adversaries seemed to cheer electoral chaos and a withering faith in democracy. Now they seem to be hoping democracy can topple a leader they’ve grown loathe to deal with.
The WHO has been criticised for being slow to recognise the scale of the COVID-9 pandemic. We suggest a new protocol on infectious diseases to help with faster data collection and more open sharing.
US farmers have suffered billions in losses due to the trade war and the coronavirus pandemic, yet surveys suggest they still back the president by a wide margin.
China represents one of the biggest consumer markets in the world. Can that potential profit offset the problems of investing for multinational corporations? Apparently, yes.
The agreement marks a key milestone in strengthening bilateral financial cooperation between the world’s largest exporter, China, and Southeast Asia’s largest economy, Indonesia.
A recent survey by the Pew Research Centre shows negative views toward China have reached their highest levels in nine countries since polling began over a decade ago.
COVID-19 pandemic has seen the Morrison government abandon long-held dogma on debt and deficits. But on climate and energy, it’s singing from the same old songbook.